Berkshire's Insurance Moat: A Value Investor's Response to the Cuban Critique

Billionaire Mark Cuban has reignited a debate about the insurance industry, directly naming Berkshire Hathaway as a company that needs to reconsider its healthcare investments. His criticism, posted on social media, focuses on the structural practice of shifting risk to independent providers and patients who lack the financial power to resist. Cuban went further, suggesting that if stockholders and IRA investors were to withdraw their capital, it could force a significant industry change. The central question for investors is whether this moral and structural critique poses a real threat to Berkshire's powerful insurance engine.

The tension here is clear. Cuban's argument highlights genuine pressures within the healthcare delivery system, framing them as a potential catalyst for market-driven divestment. Yet, this narrative of impending structural collapse stands in stark contrast to the financial reality of Berkshire's insurance operations. The company's insurance businesses are not merely participants in a troubled market; they are a primary source of its economic moat and capital generation. While the debate over risk allocation may shape public sentiment, it does not alter the fundamental economics of Berkshire's underwriting and investment portfolio.

The bottom line is that Cuban's critique, while drawing attention to industry dynamics, does not materially threaten the core value of Berkshire's insurance operations. The company's ability to compound capital over decades is built on a foundation of disciplined underwriting and a vast network of subsidiaries that operate with a long-term, value-oriented discipline. For now, the financial engine continues to run.

Financial Engine: Profitability, Scale, and the Power of Float

The Cuban critique may question the ethics of risk allocation, but it cannot dispute the financial engine that powers Berkshire. The company's insurance and reinsurance operations are not a liability; they are the primary source of its economic moat and capital. The numbers for the first nine months of 2025 tell a clear story of strength, scale, and disciplined compounding.

The headline figure is a net underwriting profit of $5.7 billion for the nine months ended September 30, 2025, a solid 1.5% increase year-on-year. This profit is the foundation of Berkshire's investment capital. More specifically, the primary insurance segment, which includes the massive GEICO, delivered a pre-tax underwriting profit of $5.767 billion. This is the core, recurring earnings stream from writing policies on cars, homes, and businesses-a business that has grown its gross written premiums by 5.6% over the past year.

The story is even more compelling when viewed through the turnaround in the reinsurance arm. After a challenging period, Berkshire's reinsurance group reported a sharp improvement, posting an $884 million pre-tax underwriting profit in the third quarter of 2025. This followed a $310 million loss in the same quarter of 2024. The improvement was driven by a significant reduction in losses and a combined ratio that improved to 79.4% in the quarter, a dramatic swing from the prior year's 97%. This demonstrates the operational discipline and risk management that allow Berkshire to navigate volatile catastrophe events, like the Southern California wildfires, and still generate substantial underwriting profits.

All of this points to the strategic genius of Warren Buffett's model. The true power lies not just in the underwriting profit, but in the massive, low-cost float that funds it. This is the capital that Berkshire uses to invest in high-quality businesses. As Buffett himself emphasized, the company's ability to compound is magnified by leverage, where shareholders' capital is multiplied by the assets under management. In effect, for every dollar invested by shareholders, Berkshire deploys roughly $1.75 of assets. The float provides this capital without the interest cost of debt, allowing Berkshire to deploy capital at scale and earn returns on a vast portfolio. It is the engine that turns underwriting profits into a self-fueling compounding machine.

The Competitive Moat: Evidence of Resilience and Confidence

The Cuban critique focuses on a perceived weakness in the insurance model. The evidence, however, points to a different story-one of resilience, disciplined capital allocation, and a powerful competitive moat that is being actively reinforced, not eroded.

The most direct counter to the narrative of systemic failure is the operational performance. Berkshire's reinsurance arm, which faced a loss last year, posted an $884 million pre-tax underwriting profit in the third quarter of 2025. This was driven by a sharp reduction in losses and a combined ratio that improved to 79.4% for the quarter, a dramatic swing from the prior year's 97%. While the company did face catastrophe losses from the Southern California wildfires, the overall trend is one of disciplined loss management. The primary insurance segment also showed strength, with a combined ratio of 89.3% in Q3, a huge improvement from the prior year. This isn't just a one-quarter bounce; it's evidence of a durable underwriting discipline that allows Berkshire to generate profits even in volatile conditions.

More telling than quarterly results is the company's strategic investment in Chubb Limited. Warren Buffett's position, now worth $9.7 billion, represents a massive vote of confidence in the long-term value of a major insurer. The stake, which has seen a 15.9% increase in shares in Q3 2025, is not a speculative trade. It is a concentrated bet on a peer with a strong market position and a proven ability to manage risk. By buying more of a leading competitor during a period of industry scrutiny, Berkshire's management is signaling that the underlying business model-and the ability to compound capital within it-remains intact and valuable.

The bottom line is that the pressures Cuban identifies are not new. They are part of the insurance cycle. What matters is how a company navigates them. Berkshire's actions speak louder than the critique. The company is not retreating from its insurance core; it is deepening its commitment to it, both through operational excellence and by deploying capital into other high-quality insurers. For a value investor, this is the hallmark of a durable moat: the ability to generate consistent profits, attract capital, and compound value even when the industry faces headwinds. The float remains a low-cost engine, and the competitive advantages are being actively fortified.

Forward Look: Catalysts, Risks, and What to Watch

The Cuban critique is a narrative, not a financial event. For the value investor, the path forward hinges on monitoring tangible metrics and catalysts that will either validate the critique or confirm the resilience of Berkshire's insurance moat.

First and foremost, watch the underwriting results. The recent improvement provides a baseline, but the real test is sustainability. The company's reinsurance arm posted an $884 million pre-tax underwriting profit in the third quarter of 2025, a dramatic swing from a loss the year before. The primary insurance segment also showed strength. However, the nine-month figures for the reinsurance group show a 11.3% decline in pre-tax underwriting profit to $1.227 billion. The key is to see if this is a cyclical dip or the start of a deterioration. Any significant, sustained rise in loss ratios or a return to underwriting losses across the portfolio would signal a broken model and would be the clearest sign that the Cuban narrative has economic traction.

Second, monitor for regulatory or legislative action. Cuban's scenario relies on a market-driven divestment fueled by public pressure. The catalyst that could make this real is government intervention. If the Department of Justice or Congress moves to regulate the specific risk-shifting practices Cuban criticized, it would directly impact Berkshire's healthcare insurance operations and its ability to generate profits from that segment. Conversely, a lack of action would likely keep the critique as a public relations issue, not a financial one.

Finally, track the performance of the float and its deployment. This is the core of Buffett's strategy. The float is not just a balance sheet item; it is the low-cost capital that powers Berkshire's compounding engine. The company's ability to deploy this capital into non-insurance businesses at attractive prices is what turns underwriting profits into long-term shareholder value. The strategic importance of this is clear: as noted in Buffett's final letter, the company's $1.2 trillion in assets are funded by only $698 billion of shareholder capital, giving each dollar of equity a powerful multiplier effect. Any sign that the float is shrinking or that its cost is rising would undermine this entire model. For now, the evidence shows a strong engine, but the value investor's job is to watch the gauges.